1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma

Author： Trowbridge Ryan   Kizer Robert T   Mittal Sumeet K   Agrawal Devendra K  

Publisher： Informa Healthcare

ISSN： 1744-666X

Source： Expert Review of Clinical Immunology, Vol.9, Iss.6, 2013-06, pp. : 517-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Advances in the Pathogenesis and Progression of Barrett’s Esophagus

By  

Current Molecular Medicine, Vol. 14, Iss. 1, 2014-01 ,pp. : 58-68

Bentham Science Publishers

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D 3 inhibits dendritic cell differentiation and maturation in vitro

By Berer A.   Stockl J.   Majdic O.   Wagner T.   Kollars M.   Lechner K.   Geissler K.   Oehler L.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 575-583

Elsevier

Access to resources Recommend Favorite

Inhibition of costimulatory pathways for T-cell activation by 1,25-dihydroxyvitamin D 3

By Penna G.   Adorini L.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2083-2084

Elsevier

Access to resources Recommend Favorite

The coming of age of 1,25-dihydroxyvitamin D 3 analogs as immunomodulatory agents

By Mathieu C.   Adorini L.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 174-179

Elsevier

Access to resources Recommend Favorite

A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets

By Malloy P.J.   Zhu W.   Bouillon R.   Feldman D.  

Molecular Genetics and Metabolism, Vol. 77, Iss. 4, 2002-12 ,pp. : 314-318

Academic Press

Access to resources Recommend Favorite